← Leaderboards
Kin Sing Stephen Lee
Michigan State University
$4,671,194
Attributed
$4,671,194
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,671,194 · 5
By mechanism
R01$1,942,815 · 1
R35$1,564,146 · 1
R00$727,268 · 1
R03$305,285 · 1
K99$131,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Michigan State University
Same institution · by research overlap
- Donald B Jump$5,296,519
- Timothy R Zacharewski$14,815,146
- Norbert E Kaminski$22,158,924
- James J Pestka$10,650,154
- James E Trosko$2,234,095
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAffectIn VivoBiologicalDesignProgramsCytochrome P450Lipid MediatorSignaling MoleculeGeneticEpoxide HydrolaseEnzymesCell TypeCellsTissuesInhibitorBiological ModelsAnalogFatty AcidsAcidsFatty Acid MetabolismIn VitroEfficacy TestingAnalytical Tool
Grant awards (15)
Development of soluble epoxide hydrolase inhibitors for the treatment of Alzheimer's disease$668,220
R01 · FY2025 · AG · contact PI
Ferroptosis and Polyunsaturated Fatty Acid Metabolism$391,250
R35 · FY2025 · GM · contact PI
Development of soluble epoxide hydrolase inhibitors for the treatment of Alzheimer's disease$624,696
R01 · FY2024 · AG · contact PI
Ferroptosis and Polyunsaturated Fatty Acid Metabolism$391,250
R35 · FY2024 · GM · contact PI
Development of soluble epoxide hydrolase inhibitors for the treatment of Alzheimer's disease$649,899
R01 · FY2023 · AG · contact PI
Ferroptosis and Polyunsaturated Fatty Acid Metabolism$391,250
R35 · FY2023 · GM · contact PI
Oxylipins, aging and Alzheimerâs disease$152,567
R03 · FY2023 · AG · contact PI
Ferroptosis and Polyunsaturated Fatty Acid Metabolism$13,173
R35 · FY2023 · GM · contact PI
Ferroptosis and Polyunsaturated Fatty Acid Metabolism$377,223
R35 · FY2022 · GM · contact PI
Oxylipins, aging and Alzheimerâs disease$152,718
R03 · FY2022 · AG · contact PI
Identifying the receptors of environmentally sensitive epoxy-eicosanoids with AMS$235,259
R00 · FY2019 · ES · contact PI
Identifying the receptors of environmentally sensitive epoxy-eicosanoids with AMS$243,009
R00 · FY2018 · ES · contact PI
Identifying the receptors of environmentally sensitive epoxy-eicosanoids with AMS$249,000
R00 · FY2017 · ES · contact PI
Identifying the Receptors of Environmentally Sensitive Epoxy-Eicosanoids with AMS$64,900
K99 · FY2016 · ES · contact PI
Identifying the Receptors of Environmentally Sensitive Epoxy-Eicosanoids with AMS$66,780
K99 · FY2015 · ES · contact PI